rethinkPeptides Search
Menu
Study breakdown

Milk-Derived Peptide Lactoferricin Kills Leukemia Cells via Oxidative Stress

In VitroPreliminary evidence
The takeaway

Lactoferricin B, a peptide from bovine milk protein, induces apoptosis in human leukemia cells through reactive oxygen species generation.

50 μg/ml Lfcin-B

Induced dose-dependent apoptosis in human leukemia cells through reactive oxygen species generation

What the researchers found

Lactoferricin B at concentrations up to 50 μg/ml induced dose- and time-dependent apoptosis in THP-1 human monocytic leukemia cells, with reactive oxygen species playing a key mechanistic role.

Why it matters

Identifying natural food-derived peptides with anticancer activity opens possibilities for novel therapeutic agents with potentially better safety profiles than conventional chemotherapy drugs.

How the study worked

In vitro cell culture study using THP-1 human monocytic leukemia cells, apoptosis assays, ROS measurement, and antioxidant intervention to confirm the oxidative stress mechanism.

What this study cannot tell us

Single cell line tested (THP-1). In vitro only — no animal or human data. Selectivity for cancer cells over normal cells not fully characterized. Bovine-derived peptide may have different activity than human lactoferricin.

How to read the evidence

Early-stage in vitro study demonstrating a novel mechanism. Promising but requires extensive validation in animal models and human studies.

When this study was published

Published in 1997, this was among the first studies to demonstrate lactoferricin's anticancer properties. Subsequent research has expanded on these findings.

The bigger picture

Lactoferricin is part of a growing body of research on bioactive peptides derived from food proteins. Its ability to selectively kill cancer cells through oxidative stress suggests that milk-derived peptides may have therapeutic applications beyond nutrition, contributing to the field of peptide-based oncology.

Questions still open

  • Does lactoferricin show selectivity for cancer cells over healthy cells?
  • Could lactoferricin be effective against solid tumors or only hematological cancers?
  • What is the optimal delivery method to achieve therapeutic concentrations in vivo?

Common questions

What is lactoferricin?
Lactoferricin is a small peptide released when the milk protein lactoferrin is digested. It has antimicrobial and, as this study shows, potential anticancer properties.
Does drinking milk give you anticancer benefits from lactoferricin?
While lactoferricin is produced during digestion of milk protein, the concentrations achieved in the body are likely much lower than those used in this lab study. More research is needed to understand dietary relevance.

Read the original research

Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species.

Biochemical and biophysical research communications, 237(3), 624-8

Citation

Yoo, Y C; Watanabe, R; Koike, Y; Mitobe, M; Shimazaki, K; Watanabe, S; Azuma, I. (1997). Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species.. Biochemical and biophysical research communications, 237(3), 624-8.